FNWA
WST icon

Financial Network Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Financial Network Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Sell
33
-7
-18% -$2.14K 0.01% 465
2026
Q1 		$10K Hold
40
– – 0.01% 465
2025
Q4 		$11K Hold
40
– – 0.01% 456
2025
Q3 		$10.5K Hold
40
– – 0.01% 449
2025
Q2 		$8.75K Sell
40
-36
-47% -$7.7K 0.01% 457
2025
Q1 		$17K Buy
76
+47
+162% +$13K 0.02% 355
2024
Q4 		$9.5K Sell
29
-102
-78% -$32.1K 0.02% 309
2024
Q3 		$39.3K Sell
131
-11
-8% -$3.37K 0.03% 302
2024
Q2 		$46.3K Buy
+142
New +$50.2K 0.03% 318

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Financial Network Wealth Advisors's WST Position: Q2 2026 in Review

Financial Network Wealth Advisors reduced its West Pharmaceutical (WST) stake by 18% in Q2 2026, selling an estimated $2.14K and leaving 33 shares worth $11.9K. The position accounts for 0.01% of the portfolio, ranked #465.

Financial Network Wealth Advisors first reported a position in WST in Q2 2024 and has held it in 9 quarters since. The position peaked at $46.3K in Q2 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Financial Network Wealth Advisors held 33 shares of West Pharmaceutical worth $11.9K as of Q2 2026.
  • Financial Network Wealth Advisors sold 7 West Pharmaceutical shares in Q2 2026, an estimated $2.14K.
  • West Pharmaceutical made up 0.01% of Financial Network Wealth Advisors's portfolio in Q2 2026, its #465 holding.
  • Financial Network Wealth Advisors first reported a position in West Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
  • Financial Network Wealth Advisors's West Pharmaceutical position peaked at $46.3K in Q2 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.